Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Franssen, Gerben M."'
Autor:
van Lith SAM; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Huizing FJ; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Franssen GM; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Hoeben BAW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands., Lok J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Doulkeridou S; Department of Cell Biology, University of Utrecht, Utrecht, 3584 GE, The Netherlands., Boerman OC; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., van Bergen En Henegouwen PMP; Department of Cell Biology, University of Utrecht, Utrecht, 3584 GE, The Netherlands., Bussink J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands., Heskamp S; Department of Medical Imaging, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2022 Oct 03; Vol. 19 (10), pp. 3511-3520. Date of Electronic Publication: 2022 Jan 19.
Autor:
van Dijk LK; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Yim CB; Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland., Franssen GM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Kaanders JH; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Rajander J; Accelerator Laboratory, Turku PET Centre, Åbo Akademi University, Turku, Finland., Solin O; Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland.; Accelerator Laboratory, Turku PET Centre, Åbo Akademi University, Turku, Finland., Grönroos TJ; MediCity/PET Preclinical Laboratory, Turku PET Centre, University of Turku, Turku, Finland., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Bussink J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Contrast media & molecular imaging [Contrast Media Mol Imaging] 2016 Jan-Feb; Vol. 11 (1), pp. 65-70. Date of Electronic Publication: 2015 Aug 04.
Autor:
Terry SY; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands Department of Imaging Sciences, Kings College London, London, United Kingdom samantha.terry@kcl.ac.uk., Abiraj K; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland; and., Lok J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gerrits D; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Franssen GM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Nov; Vol. 55 (11), pp. 1849-55. Date of Electronic Publication: 2014 Oct 27.
Autor:
van Dijk LK; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; and Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands laura.vandijk@radboudumc.nl., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Franssen GM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Lok J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; and., Kaanders JH; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; and., Bussink J; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; and.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Oct; Vol. 55 (10), pp. 1665-70. Date of Electronic Publication: 2014 Sep 18.
Autor:
van Dijk LK; Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and., Hoeben BA, Kaanders JH, Franssen GM, Boerman OC, Bussink J
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 Dec; Vol. 54 (12), pp. 2118-24. Date of Electronic Publication: 2013 Oct 17.
Autor:
van Dijk LK; Department of Radiation Oncology, Radboud University Nijmegen Medical Center, The Netherlands; Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, The Netherlands. Electronic address: l.vandijk@rther.umcn.nl., Hoeben BA, Stegeman H, Kaanders JH, Franssen GM, Boerman OC, Bussink J
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2013 Sep; Vol. 108 (3), pp. 484-8. Date of Electronic Publication: 2013 Aug 07.
Autor:
Hoeben BA; Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. b.hoeben@rther.umcn.nl, Kaanders JH, Franssen GM, Troost EG, Rijken PF, Oosterwijk E, van Dongen GA, Oyen WJ, Boerman OC, Bussink J
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2010 Jul; Vol. 51 (7), pp. 1076-83. Date of Electronic Publication: 2010 Jun 16.
Autor:
van Lith, Sanne A M, Huizing, Fokko J, Franssen, Gerben M, Hoeben, Bianca A W, Lok, Jasper, Doulkeridou, Sofia, Boerman, Otto C, Gotthardt, Martin, van Bergen En Henegouwen, Paul M P, Bussink, Johan, Heskamp, Sandra, Sub Cell Biology, Celbiologie
Publikováno v:
Molecular Pharmaceutics, 19, 3511-3520
Molecular Pharmaceutics, 19(10), 3511. American Chemical Society
Molecular Pharmaceutics, 19, 10, pp. 3511-3520
Molecular Pharmaceutics, 19(10), 3511. American Chemical Society
Molecular Pharmaceutics, 19, 10, pp. 3511-3520
Contains fulltext : 283433.pdf (Publisher’s version ) (Open Access) Hypoxic areas are present in the majority of solid tumors, and hypoxia is associated with resistance to therapies and poor outcomes. A transmembrane protein that is upregulated by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862189908a8129b2deaa66bc7d6af3a4
http://hdl.handle.net/2066/283433
http://hdl.handle.net/2066/283433